middle.news
How Entropy Neurodynamics Is Revolutionising Psychedelic Therapy with $6.1M Boost
9:30am on Friday 27th of February, 2026 AEDT
•
Healthcare
Read Story
How Entropy Neurodynamics Is Revolutionising Psychedelic Therapy with $6.1M Boost
9:30am on Friday 27th of February, 2026 AEDT
Key Points
14.8% reduction in half-year loss to $3.43 million
Initiation and dosing in world-first Binge Eating Disorder trial with TRP-8803
Secured $6.1 million placement and $2.6 million R&D loan facility
Exclusive biomarker development agreement with Imperial College London
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
ENTROPY NEURODYNAMICS (ASX:ENP)
OPEN ARTICLE